Document Detail

Spontaneous regression of congenital melanocytic nevi without evidence of the halo phenomenon.
MedLine Citation:
PMID:  12920373     Owner:  NLM     Status:  MEDLINE    
Spontaneous regression of a congenital melanocytic nevus is rare and has always been thought to be associated with a halo phenomenon, suggesting that an immunological mechanism is involved in the regression process. We describe herein 2 cases of complete congenital melanocytic nevus regression without the halo phenomenon in 2 Japanese girls. To our knowledge, such a clinical progression has not been previously reported. We will also discuss several different possible mechanisms of regression.
Toshiro Kageshita; Yuji Inoue; Tomomichi Ono
Related Documents :
21429563 - Aspergillus-related myositis: a case report and review of the literature.
20011503 - Congenital arhinia: a rare case.
18328653 - Middle ear adenoma diagnosed by recurrent facial paralysis.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Dermatology (Basel, Switzerland)     Volume:  207     ISSN:  1018-8665     ISO Abbreviation:  Dermatology (Basel)     Publication Date:  2003  
Date Detail:
Created Date:  2003-08-15     Completed Date:  2004-01-28     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9203244     Medline TA:  Dermatology     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  193-5     Citation Subset:  IM    
Copyright Information:
Copyright 2003 S. Karger AG, Basel
Department of Dermatology, Kumamoto University School of Medicine, Kumamoto, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Child, Preschool
Nevus, Pigmented / congenital*,  pathology
Remission, Spontaneous
Skin Neoplasms / congenital*,  pathology

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Lupus erythematosus tumidus in childhood. Report of 3 patients.
Next Document:  Photo recall phenomenon: an adverse reaction to taxanes.